Dongli Pan | Herpesvirus Infection | Best Researcher Award

Prof. Dr. Dongli Pan | Herpesvirus Infection | Best Researcher Award

Zhejiang University School of Medicine | China

Dr. Prof. Dongli Pan is a distinguished biochemist whose research has significantly advanced the understanding of viral pathogenesis and host-virus interactions. She earned her Ph.D. in Biochemistry from the University of Pennsylvania, Philadelphia (2001โ€“2007), where her dissertation focused on the fast kinetics of tRNA movement on the ribosome during bacterial translation elongation, following a B.S. in Chemistry from Peking University, Beijing (1997โ€“2001). Currently a Professor at the Zhejiang University School of Medicine, Dr. Panโ€™s major research interests center on the mechanisms of herpes simplex virus (HSV) infection and pathogenesis, HSV-host interactions, and anti-HSV drug development. Her research excellence has been recognized through several competitive national grants, including major projects funded by the National Key R&D Project of China and the National Natural Science Foundation of China, with total funding exceeding several million RMB. Dr. Pan has led and contributed to groundbreaking studies on viral latency, host microRNAs, and innate immune responses to DNA viruses. Before joining Zhejiang University, she conducted postdoctoral research at Harvard Medical School and the University of Pennsylvania, deepening her expertise in molecular virology. In addition to her research, Dr. Pan is a dedicated educator, actively involved in undergraduate and graduate teaching at Zhejiang University and the Zhejiang Universityโ€“University of Edinburgh Institute, where she organizes and lectures in courses such as Infection 3, Pathogens, and Medical Microbiology and Parasitology, fostering the next generation of biomedical scientists through her bilingual instruction and mentorship.

Profiles: Scopus

Featured Publications

"Inhibitory effect of Alantolactone against varicella-zoster virus in vitro", Virology JournalThis link is disabled., 2025.

"A potent protective bispecific nanobody targeting Herpes simplex virus gD reveals vulnerable epitope for neutralizing",Nature CommunicationsThis link is disabled., 2025.

"Discovery of Novel Piperazinone-Fused Hydroxypyridinones Inhibiting Herpes Simplex Virus Gene Transcription and Viral Replication", Journal of Medicinal Chemistry, 2025.

"Quantification and analysis of thymidine kinase expression from acyclovir-resistant G-string insertion and deletion mutants in herpes simplex virus-infected cells", J. Virol, 2025.

Jaina Razbek | Epidemiology | Best Scholar Award

Dr. Jaina Razbek | Epidemiology | Best Scholar Award

Xinjiang Medical University | China

Author Profile

Scopus

Orcid ID

Jaina Razbek, Ph.D. Candidate ๐Ÿฉบ๐Ÿ“Š

Pioneering Research in Tuberculosis Prevention and Genetic Epidemiology

EARLY ACADEMIC PURSUITS ๐ŸŽ“

Jaina Razbek embarked on her academic journey with a strong foundation in public health and epidemiology. She is currently pursuing her doctoral studies at the Department of Epidemiology and Health Statistics, College of Public Health, Xinjiang Medical University. Her early academic training provided her with the skills to analyze disease patterns, conduct large-scale epidemiological studies, and develop statistical models for public health interventions.

PROFESSIONAL ENDEAVORS & RESEARCH PROJECTS ๐Ÿ”ฌ๐Ÿ“š

Jaina's research primarily focuses on tuberculosis prevention and control, genetic epidemiology, and health economic evaluations. She has actively contributed to various prestigious research projects, playing critical roles in data organization, statistical analysis, and causal inference modeling.

Notable Research Projects:

๐Ÿ”น Health Economic Evaluation of Early Screening and Preventive Treatment for Latent Tuberculosis Infection (2023-2025): Investigating cost-effectiveness models for TB prevention strategies.
๐Ÿ”น Evaluation of Tuberculosis Prevention Models in Southern Xinjiang (2023-2024): Analyzing key intervention factors using cohort and implementation science frameworks.
๐Ÿ”น Causal Effect Evaluation of the โ€˜Xinjiang Modelโ€™ for TB Prevention (2025-2028): Studying the impact of TB control policies through RE-AIM and stepped-cluster randomized trials.
๐Ÿ”น Role of Vitamin D in Latent Tuberculosis Infection (2021-2024): Conducting causal inference studies on the effects of vitamin D in TB progression.

CONTRIBUTIONS & RESEARCH FOCUS ON EPIDEMIOLOGY๐Ÿ”๐Ÿ“–

Jainaโ€™s research has significantly contributed to understanding the genetic and epidemiological factors influencing tuberculosis and metabolic diseases. Her studies focus on:

โœ… Tuberculosis Prevention & Control โ€“ Developing early screening methods and evaluating intervention effectiveness.
โœ… Genetic Polymorphisms & Disease Susceptibility โ€“ Examining the role of vitamin D receptor gene polymorphisms in TB.
โœ… Public Health Strategies โ€“ Enhancing disease prevention strategies through statistical modeling and health economics.
โœ… Epidemiological Methods & Causal Inference โ€“ Applying advanced statistical frameworks to investigate complex disease mechanisms.

IMPACT & INFLUENCE ๐ŸŒ

Jaina's research has played a vital role in shaping tuberculosis prevention strategies in high-incidence regions like Xinjiang. Her contributions to causal inference in genetic epidemiology have furthered the understanding of gene-disease interactions, helping predict disease susceptibility and treatment responses.

Her involvement in major national and provincial-level research projects underscores her ability to bridge theoretical epidemiology with practical public health solutions.

ACADEMIC CITATIONS & SCHOLARLY OUTPUT ๐Ÿ“‘

Jaina Razbek has published multiple high-impact research papers in SCI-indexed journals, demonstrating her scholarly excellence. Some of her most notable publications include:

๐Ÿ“„ Vitamin D Receptor Gene Polymorphisms Differentiated Between Tuberculosis Disease and Infection โ€“ Published in Infection and Drug Resistance (2024).
๐Ÿ“„ Association of Serum Levels of TNF-ฮฑ, IL-10, IFN-ฮณ, and CXCL5 with Latent Tuberculosis โ€“ Published in Infection and Drug Resistance (2024).
๐Ÿ“„ Causal Association Study of Metabolic Syndrome Development Using Longitudinal Data โ€“ Published in Scientific Reports (2024).
๐Ÿ“„ Dynamic Progression and Risk Assessment of Metabolic Syndrome Using a Multi-State Markov Model โ€“ Published in Diabetes, Metabolic Syndrome, and Obesity (2022).
๐Ÿ“„ Xinjiang Metabolic Syndrome Risk Prediction Model Using Interpretable Models โ€“ Published in BMC Public Health (2022).

These contributions have earned her widespread recognition, with citations in public health and epidemiology research worldwide.

LEGACY & FUTURE CONTRIBUTIONS ๐Ÿ”ฎ

Jaina Razbek's research has laid the groundwork for improving tuberculosis prevention strategies through genetic and economic evaluations. Moving forward, she aims to:

๐ŸŒŸ Advance the field of epidemiological modeling for infectious diseases.
๐ŸŒŸ Develop precision medicine approaches for tuberculosis based on genetic susceptibility markers.
๐ŸŒŸ Integrate AI-driven analytics into public health decision-making.
๐ŸŒŸ Mentor future epidemiologists and expand global collaborations in disease prevention research.

CONCLUSION ๐Ÿ†

Jaina Razbek is an emerging leader in epidemiology and public health research, with a deep commitment to disease prevention and health policy optimization. Her innovative research, impactful publications, and dedication to public health continue to shape the future of tuberculosis control and epidemiological science.

NOTABLE PUBLICATIONS๐Ÿ“‘

"Causal association study of the dynamic development of the metabolic syndrome based on longitudinal data"ย 

  • Authors: Razbek, J. , Bao, L. , Zhang, Y. , Daken, M. , Cao, M.
  • Journal: Scientific Reports
  • Year: 2024

"Vitamin D Receptor Gene Polymorphisms Differentiated Between Tuberculosis Disease and Infection: Causal Association Study"ย 

  • Authors: Razbek, J. , Chen, Y. , Yang, J. , Aili, A. , Cao, M.
  • Journal: Infection and Drug Resistance
  • Year: 2024

"Association Studies of Serum Levels of TNF-ฮฑ, IL-10, IFN-ฮณ and CXCL 5 with Latent Tuberculosis Infection in Close Contacts"ย 

  • Authors: Razbek, J. , Daken, M. , Chen, Y. , Wang, X. , Cao, M.
  • Journal: Infection and Drug Resistance
  • Year: 2024

"Opening the black box: interpretable machine learning for predictor finding of metabolic syndrome"ย 

  • Authors: Zhang, Y. , Zhang, X. , Razbek, J. , Daken, M. , Cao, M
  • Journal:BMC Endocrine Disorders
  • Year: 2022

"Construction of Xinjiang metabolic syndrome risk prediction model based on interpretable models"ย 

  • Authors: Zhang, Y. , Razbek, J. , Li, D. , Zhang, X. , Cao, M.
  • Journal: BMC Public Health
  • Year: 2022